ESC Premium Access

Trimetazidine and nicorandil decrease the increment of serum creatinine in patients with normal or slightly decreased renal function after undergoing elective percutaneous coronary intervention

Congress Presentation

About the speaker

Professor Fengshuang An

Shandong University Qilu Hospital, Jinan (China)
0 follower

6 more presentations in this session

Impact of chronic kidney disease on clinical outcomes in patients with unprotected left main coronary artery disease: insights from a large-sized all-comers registry

Speaker: Assistant Professor D. Kim (Daejeon, KR)


Safety of emergency pretreatment regimen for contrast allergy before percutaneous coronary intervention for ST-elevation myocardial infarction

Speaker: Doctor K. Jha (Danville, US)


Clinical outcomes of dialysis patients treated with current generation DES for left main distal bifurcation

Speaker: Doctor Y. Watanabe (Matsudo, JP)


Evidence-practice gap in the preprocedural risk assessment for contrast-induced acute kidney injury

Speaker: Doctor S. Shoji (Durham, US)


Proenkephalin as a new glomerular filtration marker for rule-out of sustained kidney injury after cardiac catheterization: main results from the prospective PANCAKE study

Speaker: Doctor J. Geng (Hamburg, DE)


Access the full session

Poster Session 7 - Coronary Intervention

Speakers: Professor F. An, Assistant Professor D. Kim, Doctor K. Jha, Doctor Y. Watanabe, Doctor S. Shoji...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb